Jemima Seidenberg

Jemima Seidenberg is a skilled scientist currently employed at Memo Therapeutics AG since May 2020, with prior experience as a Research Associate. Jemima's background includes a Master’s degree in Biomedicine from the University of Zurich, completed in 2020, and a Bachelor’s degree in the same field from the same institution, obtained in 2018. Before entering the research domain, Jemima conducted a Master thesis project at the Center of Experimental Rheumatology at University Hospital Zurich, focusing on the role of autophagy in the fibroblast-to-myofibroblast transition of cardiac stromal gp38+ cells. Jemima also has experience in administrative support through a previous role as an Office Administrator at TELAG AG. Educational achievements include completing Matura with a focus on Biology and Chemistry at Kantonsschule Frauenfeld and obtaining a Fachmittelschulausweis from Fachmittelschule Frauenfeld.